Prediction of Thorough QT Trials based on Population Pharmacokinetic: Pharmacodynamic Analysis of Phase I Study QT Data

被引：0
|
作者：
Trame, Mirjam N.
Vik, Torbjorn [1 ,2 ]
Hamren, Ulrika Wahlby [3 ]
Henriksson, Karin M. [4 ,5 ]
Friberg, Lena E.
机构：
[1] Uppsala Univ, Pharmacometr Res Grp, Dept Pharmaceut Biosci, Uppsala, Sweden
[2] AstraZeneca R&D, AZ ECG Ctr, Molndal, Sweden
[3] AstraZeneca R&D, Clin Pharmacol & Pharmacometr, Molndal, Sweden
[4] Dept Med Sci, Uppsala, Sweden
[5] AstraZeneca R&D, Dept Epidemiol, Molndal, Sweden
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [31] Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study
    Shah, Rashmi R.
    Maison-Blanche, Pierre
    Duvauchelle, Thierry
    Robert, Philippe
    Denis, Emmanuel
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (12) : 1451 - 1459
  • [32] Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study
    Rashmi R. Shah
    Pierre Maison-Blanche
    Thierry Duvauchelle
    Philippe Robert
    Emmanuel Denis
    European Journal of Clinical Pharmacology, 2015, 71 : 1451 - 1459
  • [33] EFFICIENCY OF DIFFERENT PHASE I STUDY DESIGNS WITH REGARD TO EXPOSURE-RESPONSE ANALYSIS OF QT DATA.
    Tsamandouras, N.
    Riley, S.
    Duvvuri, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S113 - S113
  • [34] Thorough QT Analysis of a Single Dose of Pacritinib: Results of the PAC107 Study
    Buckley, Sarah
    Al-Fayoumi, Suliman
    Wang, Lixia
    Dean, James
    Suthar, Purvi
    Kaufmann, Priska
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S427 - S427
  • [35] Concentration-QTc analysis of soticlestat in healthy adults: An alternative to a thorough QT study
    Yin, Wei
    Dote, Nobuhito
    Fukase, Hiroyuki
    Imazaki, Manami
    Shimizu, Kohei
    Takeda, Shinichi
    Darpo, Borje
    Xue, Hongqi
    Asgharnejad, Mahnaz
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [36] A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects
    Schueller, Olivier
    Lohmer, Lauren
    Xue, Hongqi
    Darpo, Borje
    Patel, Jeegar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (10): : 1221 - 1232
  • [37] The Impact of Anemia on QT Interval: A Population Based Study
    Hunuk, Burak
    Cagac, Ozgur
    Erdogan, Okan
    Kepez, Alper
    Mutlu, Bulent
    Degertekin, Muzaffer
    Erol, Cetin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C146 - C146
  • [38] Four-Way Crossover Phase 1 Thorough QT Study to Assess Cardiac Safety of Domperidone and Consideration for Design and Conduct of QT/QTc Study in China
    Wang, Fangfang
    Nie, Jing
    Yang, Li
    Yang, Zhenhua
    Xu, Lin
    Wang, Liqun
    Liao, Huimin
    Li, Mengyu
    Wang, Ping
    Li, Gailing
    Li, Haiyan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (06): : 734 - 743
  • [39] NALOXEGOL CONCENTRATION-QT ANALYSIS FROM THOROUGH QT STUDY TO PREDICT QTCF INTERVAL PROLONGATION WITH PRESENCE OF DRUG-DRUG INTERACTION
    Xu, H.
    Li, J.
    Al-Huniti, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S29 - S29
  • [40] Consideration of QT/QTc interval data in a phase I study in patients with advanced cancer.
    Varterasian, M
    Fingert, H
    Agin, M
    Meyer, M
    CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5967 - 5968
12345